196 related articles for article (PubMed ID: 36111431)
21. Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra.
Rajagopal K; Bryant AJ; Sahay S; Wareing N; Zhou Y; Pandit LM; Karmouty-Quintana H
Br J Pharmacol; 2021 Jan; 178(1):172-186. PubMed ID: 32128790
[TBL] [Abstract][Full Text] [Related]
22. Modification of lysine deacetylation regulates curcumol-induced necroptosis through autophagy in hepatic stellate cells.
Sun S; Li Z; Huan S; Kai J; Xia S; Su Y; Ji S; Chen A; Wang S; Xu X; Shao J; Zhang F; Zhang B; Zhang Z; Zheng S
Phytother Res; 2022 Jun; 36(6):2660-2676. PubMed ID: 35545249
[TBL] [Abstract][Full Text] [Related]
23. Questions and controversies: the role of necroptosis in liver disease.
Dara L; Liu ZX; Kaplowitz N
Cell Death Discov; 2016; 2():16089. PubMed ID: 27924226
[TBL] [Abstract][Full Text] [Related]
24. [Effects and mechanisms of total flavones of Abelmoschus manihot in inhibiting podocyte necroptosis and renal fibrosis in diabetic kidney disease].
Chen JX; Fang QJ; Wan YG; Liu YL; Wang Y; Wu W; Tu Y; Wang MZ; Wang DG; Ge HT
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4137-4146. PubMed ID: 37802782
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
26. The role of necroptosis in pulmonary diseases.
Mizumura K; Maruoka S; Gon Y; Choi AM; Hashimoto S
Respir Investig; 2016 Nov; 54(6):407-412. PubMed ID: 27886851
[TBL] [Abstract][Full Text] [Related]
27. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
[TBL] [Abstract][Full Text] [Related]
28. MLKL: Functions beyond serving as the Executioner of Necroptosis.
Zhan C; Huang M; Yang X; Hou J
Theranostics; 2021; 11(10):4759-4769. PubMed ID: 33754026
[TBL] [Abstract][Full Text] [Related]
29. Curcumol alleviates liver fibrosis by inducing endoplasmic reticulum stress-mediated necroptosis of hepatic stellate cells through Sirt1/NICD pathway.
Sun S; Huan S; Li Z; Yao Y; Su Y; Xia S; Wang S; Xu X; Shao J; Zhang Z; Zhang F; Fu J; Zheng S
PeerJ; 2022; 10():e13376. PubMed ID: 35582617
[TBL] [Abstract][Full Text] [Related]
30. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells.
Jia Y; Wang F; Guo Q; Li M; Wang L; Zhang Z; Jiang S; Jin H; Chen A; Tan S; Zhang F; Shao J; Zheng S
Redox Biol; 2018 Oct; 19():375-387. PubMed ID: 30237126
[TBL] [Abstract][Full Text] [Related]
31. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
Mallat A; Lotersztajn S
Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
[TBL] [Abstract][Full Text] [Related]
32. A decade of cell death studies: Breathing new life into necroptosis.
Khan I; Yousif A; Chesnokov M; Hong L; Chefetz I
Pharmacol Ther; 2021 Apr; 220():107717. PubMed ID: 33164841
[TBL] [Abstract][Full Text] [Related]
33. The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.
Jacobsen AV; Pierotti CL; Lowes KN; Au AE; Zhang Y; Etemadi N; Fitzgibbon C; Kersten WJA; Samson AL; van Delft MF; Huang DCS; Sabroux HJ; Lessene G; Silke J; Murphy JM
Cell Death Dis; 2022 Apr; 13(4):291. PubMed ID: 35365636
[TBL] [Abstract][Full Text] [Related]
34. Anti-fibrotic actions of relaxin.
Samuel CS; Royce SG; Hewitson TD; Denton KM; Cooney TE; Bennett RG
Br J Pharmacol; 2017 May; 174(10):962-976. PubMed ID: 27250825
[TBL] [Abstract][Full Text] [Related]
35. Function of cAMP scaffolds in obstructive lung disease: Focus on epithelial-to-mesenchymal transition and oxidative stress.
Zuo H; Cattani-Cavalieri I; Valença SS; Musheshe N; Schmidt M
Br J Pharmacol; 2019 Jul; 176(14):2402-2415. PubMed ID: 30714124
[TBL] [Abstract][Full Text] [Related]
36. Necroptosis: A Pathogenic Negotiator in Human Diseases.
Chaouhan HS; Vinod C; Mahapatra N; Yu SH; Wang IK; Chen KB; Yu TM; Li CY
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361505
[TBL] [Abstract][Full Text] [Related]
37. A narrative review of the role of necroptosis in liver disease: a double-edged sword.
Li X; Dong G; Xiong H; Diao H
Ann Transl Med; 2021 Mar; 9(5):422. PubMed ID: 33842643
[TBL] [Abstract][Full Text] [Related]
38. Necroptosis Signaling Pathways in Stroke: From Mechanisms to Therapies.
Jun-Long H; Yi L; Bao-Lian Z; Jia-Si L; Ning Z; Zhou-Heng Y; Xue-Jun S; Wen-Wu L
Curr Neuropharmacol; 2018; 16(9):1327-1339. PubMed ID: 29663889
[TBL] [Abstract][Full Text] [Related]
39. Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.
Chen R; Feng Y; Wu J; Song Y; Li H; Shen Q; Li D; Zhang J; Lu Z; Xiao H; Zhang Y
Br J Pharmacol; 2018 Apr; 175(8):1217-1229. PubMed ID: 28230250
[TBL] [Abstract][Full Text] [Related]
40. Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis: A Novel Therapeutic Target in Nervous System Diseases.
Tang L; Liu S; Li S; Chen Y; Xie B; Zhou J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
